Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues:
Premiums	$ 50,640	$ 47,513
Products	8,431	8,072
Services	4,985	4,318
Investment and other income	365	405
Total revenues	64,421	60,308
Operating costs:
Medical costs	41,000	38,939
Operating costs	10,015	8,517
Cost of products sold	7,687	7,381
Depreciation and amortization	723	639
Total operating costs	59,425	55,476
Earnings from operations	4,996	4,832
Interest expense	(437)	(400)
Earnings before income taxes	4,559	4,432
Provision for income taxes	(1,094)	(875)
Net earnings	3,465	3,557
Earnings attributable to noncontrolling interests	(83)	(90)
Net earnings attributable to UnitedHealth Group common shareholders	$ 3,382	$ 3,467
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic	$ 3.56	$ 3.62
Diluted	$ 3.52	$ 3.56
Basic weighted-average number of common shares outstanding	949	958
Dilutive effect of common share equivalents	13	17
Diluted weighted-average number of common shares outstanding	962	975
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	10	8